Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara L Van Driest

Showing results (1-10 of 128) with videos related to

Pageof 13
Sort By:
Clinical Pharmacology and Therapeutics|August 19, 2021
Progress and Challenges in PharmacogenomicsSara L Van Driest, Ingolf Cascorbi
Clinical Pharmacology and Therapeutics|April 4, 2019
Real-World Data for Pediatric Pharmacometrics: Can We Upcycle Clinical Data for Research Use?Sara L Van Driest, Leena Choi
Pediatrics|May 31, 2020
Authors' ResponseSara L Van Driest, Christiana J Bernal
Personalized Medicine|December 24, 2013
Pharmacogenetics in clinical pediatrics: challenges and strategiesSara L Van Driest, Tracy L McGregor
Circulation|February 4, 2015
Pharmacogenomics: personalizing pediatric heart transplantationSara L Van Driest, Steven A Webber
Clinical Pharmacology and Therapeutics|July 15, 2020
Induced Pluripotent Stem Cells: From the Bedside to the Bench, and Hopefully Back AgainSara L Van Driest, Piet H van der Graaf
Journal of the American College of Cardiology|November 1, 2005
Are longitudinal, natural history studies the next step in genotype-phenotype translational genomics in hypertrophic cardiomyopathy?Michael J Ackerman, Sara L Van Driest, Martijn Bos
JAMA|June 15, 2016
Long QT Syndrome and Potentially Pathogenic Genetic Variants--In ReplySara L Van Driest, Quinn S Wells, Dan M Roden
Expert Opinion on Drug Metabolism & Toxicology|March 15, 2023
A fresh look at proton pump inhibitor (PPI)-associated adverse events through a CYP2C19 pharmacogenetic lensRachel Chevalier, Thomas Attard, Sara L Van Driest, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 1, 2019
Reply to Wasko et alRyan K Dare, Sara L Van Driest, Thomas R Talbot
Pageof 13

Showing results (1-10 of 128) with videos related to

Sort By:
Pageof 13
Clinical Pharmacology and Therapeutics|August 19, 2021
Progress and Challenges in PharmacogenomicsSara L Van Driest, Ingolf Cascorbi
Clinical Pharmacology and Therapeutics|April 4, 2019
Real-World Data for Pediatric Pharmacometrics: Can We Upcycle Clinical Data for Research Use?Sara L Van Driest, Leena Choi
Pediatrics|May 31, 2020
Authors' ResponseSara L Van Driest, Christiana J Bernal
Personalized Medicine|December 24, 2013
Pharmacogenetics in clinical pediatrics: challenges and strategiesSara L Van Driest, Tracy L McGregor
Circulation|February 4, 2015
Pharmacogenomics: personalizing pediatric heart transplantationSara L Van Driest, Steven A Webber
Clinical Pharmacology and Therapeutics|July 15, 2020
Induced Pluripotent Stem Cells: From the Bedside to the Bench, and Hopefully Back AgainSara L Van Driest, Piet H van der Graaf
Journal of the American College of Cardiology|November 1, 2005
Are longitudinal, natural history studies the next step in genotype-phenotype translational genomics in hypertrophic cardiomyopathy?Michael J Ackerman, Sara L Van Driest, Martijn Bos
JAMA|June 15, 2016
Long QT Syndrome and Potentially Pathogenic Genetic Variants--In ReplySara L Van Driest, Quinn S Wells, Dan M Roden
Expert Opinion on Drug Metabolism & Toxicology|March 15, 2023
A fresh look at proton pump inhibitor (PPI)-associated adverse events through a CYP2C19 pharmacogenetic lensRachel Chevalier, Thomas Attard, Sara L Van Driest, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 1, 2019
Reply to Wasko et alRyan K Dare, Sara L Van Driest, Thomas R Talbot
Pageof 13